Category: Press Release - Page 157 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Silo Wellness Closes $2.5 Million Subscription Receipt Financing With Another $2.4 Million in Escrow

Silo Wellness Closes $2.5 Million Subscription Receipt Financing With Another $2.4 Million in Escrow

Post published:February 5, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Strategic Investment of $2,000,000

Tryp Therapeutics Announces Strategic Investment of $2,000,000

Post published:February 5, 2021
Post category:Press Release

Read more about the article Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD

Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD

Post published:February 4, 2021
Post category:Press Release

Read more about the article Cybin Announces Closing of Upsized Bought Deal Offering

Cybin Announces Closing of Upsized Bought Deal Offering

Post published:February 4, 2021
Post category:Press Release

Read more about the article PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements

PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements

Post published:February 4, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Veteran Jonna Birgans to Oversee Digital and VR Content Development

Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Veteran Jonna Birgans to Oversee Digital and VR Content Development

Post published:February 4, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease

PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease

Post published:February 4, 2021
Post category:Press Release

Read more about the article Dr. Roger McIntyre Announces Changes to the Board of Champignon Brands Inc.

Dr. Roger McIntyre Announces Changes to the Board of Champignon Brands Inc.

Post published:February 4, 2021
Post category:Press Release

Read more about the article Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Post published:February 4, 2021
Post category:Press Release

Read more about the article Aion Therapeutic Grants Stock Options; Announces Management Change

Aion Therapeutic Grants Stock Options; Announces Management Change

Post published:February 4, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.